Who makes REGE pro dressing?

REGE pro dressing is developed by Egyptian Atomic Energy Authority.

What development phase is REGE pro dressing in?

REGE pro dressing is in Phase 1.

Last reviewed 2026-04-19 · How we verify

REGE pro dressing

Egyptian Atomic Energy Authority · Phase 1 active Biologic

At a glance

Generic name	REGE pro dressing
Sponsor	Egyptian Atomic Energy Authority
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Uses of Irradiated Human Amniotic Membrane in the Treatment of Dystrophic Epidermolysis Bullosa Patients (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

REGE pro dressing CI brief — competitive landscape report
REGE pro dressing updates RSS · CI watch RSS
Egyptian Atomic Energy Authority portfolio CI